Cargando…

Heterogeneity of asthma–COPD overlap syndrome

Many patients suffering from asthma or COPD have overlapping features of both diseases. However, a phenotypical approach for evaluating asthma–COPD overlap syndrome (ACOS) has not been established. In this report, we examined the phenotypes in patients with ACOS. Patients diagnosed with ACOS between...

Descripción completa

Detalles Bibliográficos
Autores principales: Joo, Hyonsoo, Han, Deokjae, Lee, Jae Ha, Rhee, Chin Kook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327913/
https://www.ncbi.nlm.nih.gov/pubmed/28260876
http://dx.doi.org/10.2147/COPD.S130943
_version_ 1782510819934732288
author Joo, Hyonsoo
Han, Deokjae
Lee, Jae Ha
Rhee, Chin Kook
author_facet Joo, Hyonsoo
Han, Deokjae
Lee, Jae Ha
Rhee, Chin Kook
author_sort Joo, Hyonsoo
collection PubMed
description Many patients suffering from asthma or COPD have overlapping features of both diseases. However, a phenotypical approach for evaluating asthma–COPD overlap syndrome (ACOS) has not been established. In this report, we examined the phenotypes in patients with ACOS. Patients diagnosed with ACOS between 2011 and 2015 were identified and classified into four phenotype groups. Group A was composed of patients who smoked <10 pack years and had blood eosinophil counts ≥300. Group B was composed of patients who smoked <10 pack years and had blood eosinophil counts <300. Group C was composed of patients who smoked ≥10 pack years and had blood eosinophil counts ≥300. Group D was composed of patients who smoked <10 pack years and had blood eosinophil counts <300. Clinical characteristics were analyzed and compared among groups. Comparisons were made among 103 ACOS patients. Patients in group D were oldest, while patients in group A were youngest. There were relatively more female patients in groups A and B; the majority of patients in groups C and D were male. The degree of airflow obstruction was most severe in group C. The rate of being free of severe exacerbation was significantly lower in group C than in the other groups. In this study, each ACOS phenotype showed different characteristics. The proportion of patients free of severe exacerbation differed significantly among groups. At this time, further studies on the phenotypes of ACOS are required.
format Online
Article
Text
id pubmed-5327913
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-53279132017-03-03 Heterogeneity of asthma–COPD overlap syndrome Joo, Hyonsoo Han, Deokjae Lee, Jae Ha Rhee, Chin Kook Int J Chron Obstruct Pulmon Dis Original Research Many patients suffering from asthma or COPD have overlapping features of both diseases. However, a phenotypical approach for evaluating asthma–COPD overlap syndrome (ACOS) has not been established. In this report, we examined the phenotypes in patients with ACOS. Patients diagnosed with ACOS between 2011 and 2015 were identified and classified into four phenotype groups. Group A was composed of patients who smoked <10 pack years and had blood eosinophil counts ≥300. Group B was composed of patients who smoked <10 pack years and had blood eosinophil counts <300. Group C was composed of patients who smoked ≥10 pack years and had blood eosinophil counts ≥300. Group D was composed of patients who smoked <10 pack years and had blood eosinophil counts <300. Clinical characteristics were analyzed and compared among groups. Comparisons were made among 103 ACOS patients. Patients in group D were oldest, while patients in group A were youngest. There were relatively more female patients in groups A and B; the majority of patients in groups C and D were male. The degree of airflow obstruction was most severe in group C. The rate of being free of severe exacerbation was significantly lower in group C than in the other groups. In this study, each ACOS phenotype showed different characteristics. The proportion of patients free of severe exacerbation differed significantly among groups. At this time, further studies on the phenotypes of ACOS are required. Dove Medical Press 2017-02-22 /pmc/articles/PMC5327913/ /pubmed/28260876 http://dx.doi.org/10.2147/COPD.S130943 Text en © 2017 Joo et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Joo, Hyonsoo
Han, Deokjae
Lee, Jae Ha
Rhee, Chin Kook
Heterogeneity of asthma–COPD overlap syndrome
title Heterogeneity of asthma–COPD overlap syndrome
title_full Heterogeneity of asthma–COPD overlap syndrome
title_fullStr Heterogeneity of asthma–COPD overlap syndrome
title_full_unstemmed Heterogeneity of asthma–COPD overlap syndrome
title_short Heterogeneity of asthma–COPD overlap syndrome
title_sort heterogeneity of asthma–copd overlap syndrome
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327913/
https://www.ncbi.nlm.nih.gov/pubmed/28260876
http://dx.doi.org/10.2147/COPD.S130943
work_keys_str_mv AT joohyonsoo heterogeneityofasthmacopdoverlapsyndrome
AT handeokjae heterogeneityofasthmacopdoverlapsyndrome
AT leejaeha heterogeneityofasthmacopdoverlapsyndrome
AT rheechinkook heterogeneityofasthmacopdoverlapsyndrome